Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Jul;35(7):e432-e433.
doi: 10.1111/jdv.17271. Epub 2021 May 22.

Good tolerance of hyaluronic acid injections during the period of the COVID-19 pandemic: observing a cohort of 1093 patients in a prospective, observational real-life study

M Naouri  1   2 , S Dahan  3 , A Le Pillouer Prost  4 , P Coutant-Foulc  5 , C Raimbault  6 , F Cucurella  7 , L Beille  8 , M Creusot  9 , M Baspeyras  10 , M Darchy  11 , R Khallouf  12 , H Cartier  13 , I Baratte  14 , M Dubois  15 , O Cogrel  16 , H Laubach  17   18 ; Groupe de Dermatologie Esthétique et Correctrice de la Société Française de Dermatologie (GDEC)
Affiliations
Observational Study

Good tolerance of hyaluronic acid injections during the period of the COVID-19 pandemic: observing a cohort of 1093 patients in a prospective, observational real-life study

M Naouri et al. J Eur Acad Dermatol Venereol. 2021 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

None.

References

    1. Andre P. Evaluation of the safety of a non‐animal stabilized hyaluronic acid (NASHA ‐ Q‐Medical, Sweden) in European countries: a retrospective study from 1997 to 2001. J Eur Acad Dermatol Venereol. 2004; 18: 422–425. 10.1111/j.1468-3083.2004.00934.x. - DOI - PubMed
    1. Beleznay K, Carruthers JD, Carruthers A, Mummert ME, Humphrey S. Delayed‐onset nodules secondary to a smooth cohesive 20 mg/mL hyaluronic acid filler: cause and management. Dermatol Surg 2015; 41: 929–939. - PubMed
    1. Alijotas‐Reig J, Garcia‐Gimenez V. Delayed immune‐mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long‐term follow‐up and review of the literature. J Eur Acad Dermatol Venereol 2008; 22: 150–161. - PubMed
    1. Descamps V, Landry J, Francès C, Marinho E, Ratziu V, Chosidow O. Facial cosmetic filler injections as possible target for systemic sarcoidosis in patients treated with interferon for chronic hepatitis C: two cases. Dermatology 2008; 217: 81–84. - PubMed
    1. Humphrey S, Jones DH, Carruthers JD et al. Retrospective review of delayed adverse events secondary to treatment with a smooth, cohesive 20‐mg/mL hyaluronic acid filler in 4500 patients. J Am Acad Dermatol 2020; 83: 86–95. - PubMed

Substances